Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
38 participants
INTERVENTIONAL
2017-02-01
2018-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Research participants will have their preferred cadence evaluated at the beginning of the study. The athletes will be randomly assigned to two groups. One group will continue to train without intervention and the other group will train at a cadence of 10% higher than their preferred step rate.
At the end of 6 weeks the participants will have their preferred cadence reevaluated using the same method as pre-participation cadence was determined.
The investigators hypothesis the preferred running cadence of recreational runners following the intervention will be 5-10% greater than prior to the intervention and the increased cadence will be maintained for 6 months following the intervention.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Trial on the Effects of Home-based Five Plus Exercise Training
NCT02310256
Cadence and Intensity Across the Adult Lifespan
NCT02650258
Impact of Augmenting Exercise Intensity vs. Frequency
NCT04295590
Two Time a Week vs. Five Time a Week Blood Flow Restriction Training Program for the Lower Extremity.
NCT05342909
Physiological and Perceptual Responses During 4-Second Exercise
NCT06912932
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Group
This group will undergo home exercise program designed to increase their running cadence.
Change in running cadence
The intervention will involve a home exercise program designed to increase the running cadence in recreational runners.
Control Group
This group will not receive any intervention.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Change in running cadence
The intervention will involve a home exercise program designed to increase the running cadence in recreational runners.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years of age or greater
* run two or more times per week most weeks of the year for at least 4 years
* cadence of 85 strides/min or less as determined at initial evaluation
* no musculoskeletal injuries or illnesses that would limit running in the last 6 months
* currently running at least 15 miles a week
Exclusion Criteria
* inability to run
* cardiovascular disease
* greater than 2 cardiovascular risk factors
* peripheral vascular disease
* neurological disease
* musculoskeletal injury or disease that causes pain with running
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jonathan T. Finnoff
Professor of Physical Medicine and Rehabilitation
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jonathan T Finnoff
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16-008532
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.